Dr. Dongbin Xu is board certified by the American Board of Medical Genetics and Genomics in Clinical Cytogenetics and is the Director of Clinical Cytogenetics for HematoLogics. Dr. Xu obtained his Master’s degree in genetics from Fudan University, Shanghai, China, in 2003. He then came to the United States in 2003 and earned his doctorate degree in biomedical science from the University of Texas M.D. Anderson Cancer Center at Houston in 2009. Two years later, he completed a fellowship in cytogenetics at The Children’s Hospital of Philadelphia.
In 2012, Dr. Xu joined Shodair Children’s Hospital as the Director of Genetics Laboratory. Dr. Xu expanded multiple FISH testing panels for Leukemia and Lymphomas and imitated a clinical exome sequencing project using next-generation sequencing while he was managing the Shodair Genetics Laboratory to perform routine cytogenetic, SNP microarray, molecular genetic testing for inheritable genetic disorders, and hemato-oncology diseases. He is the author of dozens of articles regarding programmed cell death, cohesion-related human genetic disorders, disease modeling using stem cells, and diseases caused by chromosomal abnormalities. In October of 2015, Dr. Xu joined HematoLogics as the Director of Clinical Cytogenetics.
Dr. Xu is a fellow of the American College of Medical Genetics and Genomics. His area of specialty is cytogenetics, molecular cytogenetics (FISH), SNP microarray, and clinical molecular genetics, including next-generation sequencing.